BS-194

• CAT Number: I005066
• CAS Number: 1092443-55-4
• Molecular Formula: C20H27N5O3
• Molecular Weight: 385.46
• Purity: ≥95%
• Synonyms: (2S,3S)-3-[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]butane-1,2,4-triol
• InChI: InChI=1S/C20H27N5O3/c1-13(2)15-10-22-25-19(21-9-14-6-4-3-5-7-14)8-18(24-20(15)25)23-16(11-26)17(28)12-27/h3-8,10,13,16-17,21,26-28H,9,11-12H2,1-2H3,(H,23,24)/t16-,17+/m0/s1
• InChIKey: KRIWIRSMQRQYJG-DLBZAZTESA-N
• SMILES: CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)N[C@@H](CO)[C@@H](CO)O

BS-194（Cat No.:I005066）is a selective inhibitor of the mitochondrial protein GSK-3β (glycogen synthase kinase 3 beta), involved in regulating various cellular processes such as cell survival, metabolism, and inflammation. By targeting GSK-3β, BS-194 modulates signaling pathways related to neurodegenerative diseases, cancer, and metabolic disorders. It has shown potential in preclinical studies for treating conditions like Alzheimer’s disease and type 2 diabetes. BS-194’s ability to inhibit GSK-3β with high specificity makes it a promising candidate for further research and development in therapeutic applications related to neurodegeneration and metabolic dysregulation.